RP

Rakesh Parimi

Active Director Director DIN 08837682
DIN 08837682 First appointment Aug 2020 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Parimi

Data last updated:

Rakesh Parimi is a Director at Manushi Clinical Research Private Limited (since 2020). The company operates in Research & Development.

DIN 08837682
Primary Designation Director
Industry Research & Development
First Appointment 18 Aug 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Aug 20202020Active

Board colleagues of Rakesh Parimi

NameDINCompanyDesignation
Eedara Prasanna08837693Manushi Clinical Research Private LimitedDirector

Directorship timeline

Open interactive timeline →
Manushi Clinical Research Private Limited
Premium access

Shareholding and investment profile for Rakesh Parimi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Parimi

Rakesh Parimi currently holds 1 directorship: Manushi Clinical Research Private Limited (Director, since 18 Aug 2020).

Rakesh Parimi was first appointed on 18 Aug 2020 as Director at Manushi Clinical Research Private Limited.

The current boards of Rakesh Parimi's companies include Eedara Prasanna (Manushi Clinical Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available